rps138_slide_obat-obat_dalam_masa_kehamilan(2)
-
Upload
maulana-taufik -
Category
Documents
-
view
216 -
download
0
Transcript of rps138_slide_obat-obat_dalam_masa_kehamilan(2)
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
1/30
-
Tri Widyawati - Datten Bangun
Departemen Farmakologi & Terapeutik
2007
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
2/30
-
oleh ibu hamil dapat melewati plasenta danda at masuk ke tubuh anin
Efek farmakologi
e era ogen
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
3/30
PharmacokineticsCritical factors affecting placental drug transfer anddrug effects on fetus :
1. Physicochemical properties of the drug
.
3. The amount of drug reaching the fetus
.
5. Distribution characteristic in different fetal
6. The stage of placental and fetal development at
7. The effects of drugs used in combination
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
4/30
.1. Li ho hilic dru s :
- tends to diffuse readily across the placenta- enter the fetal circulation
Thiopental (used during caesarean section) :
cross the placenta immediately can produce sedation or apnea in the new
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
5/30
..
- cross the placenta slowly achieve lowconcentration in the fetus
Succinylcholine or tubocurarine
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
6/30
.
. , - -
concentration gradient cross the placenta
Salicylate
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
7/30
B. Molecular SizeDrugs with mol. weight :
- -
- 500-1000 : more difficulty- > 1000 : poorly
Heparin :- very arge an po ar una e to cross t e p acenta
- safe to the fetus
- Warfarin : - smaller than heparin
-
- should be avoided
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
8/30
.
-.
back to the maternal circulation
- cancer drugs (vinblastin, doxorubicin)- digoxin
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
9/30
.
,
barbiturates, phenytoin, local anaesthetics
plasma than in fetal plasma because of
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
10/30
.
- semipermeable barrier
- s te o meta o sm
2. Drugs enter the fetal circulation
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
11/30
PharmacodynamicsA. Maternal Drug Actions
- e e ec s o rugs on repro uc ve ssuesof the pregnant woman sometimes are alteredby endocrine environment appropriate for thestage o t e pregnancy.
- Drug effects on other system tissue (heart,significantly, though sometimes cardiac outputor renal blood flow maybe altered
.insulin for pregnancy induced diabetic
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
12/30
PharmacodynamicsB. Therapeutic Drug Actions in The Fetus
- Drugs are given to the mother with thefetus as the target of the drug
Examples:
maturation when preterm birth is expected.
jaundice
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
13/30
.
- chronic used of opioid by mothers drug
- ACE-I used by the mothers renalamage n e e us
- diethylstilbesterol adenocarcinoma
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
14/30
Pharmacod namicsD. Teratogenicity
Teratos = monster
malformed baby
Teratogen :* result in a characteristic set of malformation
* exerts its effect at a particular stage of fetal
eve opment organogenes s* show a dose-dependence incidence
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
15/30
Teratogenic Action of Drugs influenced by :
Dose
requency
Length of exposure Stage of pregnancy upon exposure
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
16/30
Schematic Diagram of Critical Periods of Human
Development
Prenatal death Major morphologic abnormalitiesPhysiologic defect and minor
morphologic abnormalities
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
17/30
Poorl understood
Probably multifactorial :- maternal tissue
- differentiation process in the fetal tissue
* vit. A (retinol)- deficiency of critical substance
* folic acid deff. spina bifida
- chronic consumption of high dose of ethanol fetal alcohol syndrome
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
18/30
Pregnancy Safety Index (US FDA)ategory :
- controlled studies in women (+)- fail to demonstrate a risk to the fetus in 1st semesterand later
Category B:- -* no foetal risk, but no controlled studies in pregnant
womens own an a verse e ec , u no con rme n con ro e
studies in women in 1st semester or later
Category C:
- studies in animal revealed adverse effect (teratogenic orembryogenic or other)- no controlled studies in women
Drugs should be given only if the potential benefit justifies
the potential risk to the fetus
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
19/30
Pr n n f In x FDA
- there is positive evidence of human foetal risk, but thebenefits for the pregnant women may be acceptable (if the
Cate or X:- studies in animal and human being foetal abnormalities- evidence of foetal risk based on human experience
-outweights any possible benefit The drug is contraindicated in women who are or may
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
20/30
Dru s to avoid in Pre nancPregnancy risk Description of Drugs to avoid
Unsafe
Acitretin, clomiphene,cocaine, ergots, ethanol,
XAbsolutely
contraindicated
HMG-CoA reductaseinhibitors, isotretinoin,
misoprostol, nicotin,premarin, quinine,
raloxifen, thalidomide
DEvidence of risk, but incertain circumtances,
ACE-I, angiotensinantagonist (2nd and 3rd
semesters),
use maybe justifiable am nog ycos es
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
21/30
st
Teratogen
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
22/30
Drug Effect Prenatal diagnosis
um ar ac e ec s
(Ebstein complex)
eas e
Warfarin Chondrodysplasia punctata Unlikely
Facial anomalies
Severe anomalies of CNS
Unlikely
Unlikely
Phenytoin Craniofacial Feasible
Limb
Growth deficiency
Feasible
Feasible
Sodium valproate CNS Feasible
Carbamazepine Craniofacial
Fingernail
Feasible
Feasible
Sex hormone Cardiac defectsMultiple anomalies
FeasibleFeasible
Retinoic acids Craniofacial Feasible
Cardiac
CNS
Feasible
Feasible
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
23/30
Drugs Given After The 1st Trimester
,
moves from structural to physiologice ec s
Sometimes adverse effects occur in
the mother
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
24/30
1. He arin : threatens mother rather than the fetus
- unfractionated heparin given to pregnantwomen 20.000 unit/day for 3 months
os eoporos s rac ure ver e rae
- risk is less with low-molecular-weight
2. Warfarin : damage the fetus, by causing bleeding into the
fetal brain, eventhough the mothers anticoagulant
control is good
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
25/30
Antibiotic and Pregnancy
Considered safe Maybe safe, can be used in certain
circumstances
Should be avoided
Pnc G Trimethoprim/fetal abnormalities at 1st
Tm folate antagonist
Chloramphenicol
Pnc V Tetracycline
Ampicillin Aminoglycoside
Amoxycilline SulfonamideErythromycin Erythromycin estolate (cholestasis) Metronidazole
Floxacillin Ciprofloxacin
ep a ospor n a om eIsoniazid Rifampicinhemorrhagic disease :
give vit. K
Ethambutol
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
26/30
Antibiotic and Pregnancy
Chloramphenicol Not teratogenic but gray baby
Tetracycline Tooth discoloration, enamelhypoplasia, bone hypoplasia and
Aminoglycoside Fetal citotoxicity
u onam e ven c ose to e very ern-icterus and hemolytic anaemia
Ciprofloxacin Fetal cartilage damage
Thalidomide For leprosy phocomelia
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
27/30
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
28/30
Use paracetamol
Indomethacin could close the ductus
arteriosus rematurel
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
29/30
Cancer Chemotherapy During Pregnancy
1. 1st trimester :-
teratogens- the risk for malformation 10% for singleagen an or com na on
2. Second and trimester :
-teratogenesis, but could have non teratogeniceffects
x. : owBrain development disturbances
-
8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)
30/30